Elucidating the exact pharmacological system of action (MOA) of naturally developing compounds can be hard. While Tarselli et al. (60) created the very first de novo synthetic pathway to conolidine and showcased this naturally taking place compound proficiently suppresses responses to equally chemically induced and inflammation-derived pain, the ph